Literature DB >> 8558648

Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.

G J Faerber1.   

Abstract

PURPOSE: The safety and efficacy of collagen injection therapy for the treatment of type I stress urinary incontinence were determined.
MATERIALS AND METHODS: A total of 12 women 68 to 85 years old (mean age 76) with type I stress urinary incontinence underwent collagen injection. Incontinence was subjectively categorized as grades 0 to 3, and Valsalva leak point pressures were measured before and after injection.
RESULTS: At a mean of 10.3 months (range 3 to 24) 10 of the 12 women (83%) were cured, while the remaining 2 noticed subjective improvement in incontinence. Average number of injections per patient was 1.25 (1 injection in 9 and 2 in 3), average total collagen injected per patient was 2.2 cc (range 1.0 to 3.5) and average increase in Valsalva leak point pressure after collagen injection was 22 cm. water (range 0 to 40).
CONCLUSIONS: Collagen injection appears to be an effective alternative method for the treatment of type I stress urinary incontinence in elderly women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558648

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

Review 2.  Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.

Authors:  Niall F Davis; F Kheradmand; T Creagh
Journal:  Int Urogynecol J       Date:  2012-12-08       Impact factor: 2.894

Review 3.  Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result.

Authors:  E J McGuire; S F English
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile.

Authors:  Lindsey A Kerr
Journal:  Rev Urol       Date:  2005

5.  Functional outcomes of adjustable continence therapy (ACT™) balloons in women aged >80 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiency.

Authors:  Claire Billault; Emmanuel Chartier-Kastler; Morgan Rouprêt; Gilberte Robain; Véronique Phé
Journal:  World J Urol       Date:  2015-02-21       Impact factor: 4.226

6.  Collagen injections for genuine stress urinary incontinence: patient selection and durability.

Authors:  S Herschorn; S B Radomski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

7.  Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections.

Authors:  Jane A Schulz; Charles W Nager; Stuart L Stanton; Kaven Baessler
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

Review 8.  Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 9.  A transperitoneal laparoscopic approach to endourology.

Authors:  A M Kaynan; H N Winfield
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

Review 10.  Use of collagen for the treatment of stress urinary incontinence: an update.

Authors:  M B Tchetgen; R A Appell
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.